GSK rare disease unit

Screen Shot 2013-11-06 at 18.18.32The Brazilian state of São Paulo is to create a Centre of Excellence for research in sustainable chemistry.

The Centre, financed jointly by UK pharmaceutical group GlaxoSmithKline (GSK) and the São Paulo Research Foundation (FAPESP), is expected to usher in a new age of “green chemistry” as the precursor of new generations of medicines.

FAPESP and GSK will share equally the funding of £800, 000 per year for a period of 10 years. This is the second such unit sponsored by GSK. In 2012, the University of Nottingham in the UK began work on company its own Centre of Excellence in Sustainable Chemistry.

Once completed, the new São Paulo centre of excellence will form scientific links with GSK and the University of Nottingham for facilitating the sharing of knowledge and expertise between Brazilian and UK researchers.

Screen Shot 2013-11-06 at 18.16.27To be located in the state of São Paulo, the new Centre of Excellence will have a multidisciplinary approach, seeking greater efficiency in the use of synthetics and in the development of reagents and solvents using feedstocks such as renewable agricultural waste.

This initiative will bring alternatives to the processes and components used today in the pharmaceutical industry, which will allow GSK to incorporate the use of new sustainable chemicals, so contributing directly to meeting targets for reducing carbon emissions.

The agreement was signed in São Paulo 24th October at the administrative headquarters of São Paulo’s state government in the presence of state governor Governor Geraldo Alckmin. On the FAPESP side senior officials including President Geraldo Alckmin and scientific director Carlos Henrique de Brito Cruz were present. For GSK the agreement was signed by Rogério Ribeiro, GSK’s senior vice president and general manager of EMAP (Emerging Markets and Asia Pacific) and by Cesar Rengifo, vice president and general manager of GSK Brazil.

According to the pharmaceutical company’s Rogério Ribeiro: “GSK has a booming business in Brazil. We are delighted to announce our support the new Centre of Excellence for Research in Sustainable Chemistry, an initiative that is part of our continued investment in science. This will contribute decisively to achieving our goal of reducing environmental impact and becoming carbon-neutral by 2050, ” he said.

Mr Ribeiro noted the company has a vibrant and growing business in Brazil and, as part of its continued investment in science in Brazil, it is delighted to announce the support for the new sustainable chemistry centre.

Strange Rare Diseases You Have to See to Believe  — Top Secret Writers
We are both curious and fearful of any new disease that we hear about. We stayed glued to the TV news if we hear of an “outbreak” of some sort. We fear as much as we investigate.

AB Natural Balance Kava Kava Root 450 mg, Veggie Caps 60 ea
Health and Beauty (AB)
  • Natural Balance Kava Kava Root 450 mg, Veggie Caps 60 ea
  • *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Warnings...
AB Natural Balance Happy Camper Herbal Formula, Veggie Caps 60 ea
Health and Beauty (AB)
  • Natural Balance Happy Camper Herbal Formula, Veggie Caps 60 ea
  • *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.WarningsThe...
AB Gaia Herbs Kava Kava Root, Vegetarian Liquid Phyto-Capsules 60 ea
Health and Beauty (AB)
  • Gaia Herbs Kava Kava Root, Vegetarian Liquid Phyto-Capsules 60 ea
  • WarningsUS FDA advises the a potential risk of rare, but severe, liver injury may be associated with kava-containing dietary supplements. Do not take if you have...
Related Posts